GW-501516 (Cardarine)

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

GW-501516 (Cardarine)

A peroxisome proliferator-activated receptor agonist that was never approved for human use.

Evidence category: Preclinical. This describes the source category, not approval or certainty.

Regulatory statement in source: Not FDA-approved.

GW-501516 (Cardarine) is a peroxisome proliferator-activated receptor delta (PPARδ) agonist investigated for dyslipidemia and metabolic disorders. It activates PPARδ with 1000-fold selectivity over PPARα. Research indicates effects on lipid metabolism, mitochondrial respiration, and metabolic disorders. However, it was never approved for human use and is not FDA-approved.

Benefits reported in the imported source

• Selective PPARδ agonist; effects on lipid and glucose metabolism in preclinical models

Risks and limits

• Concerns about cancer risk from animal studies

Source bottom line: Preclinical research only; development abandoned before approval; not approved for human use.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

No community description recorded. This entry has no final B-82 outcome record; it is not a researched-empty finding.

Pharmacokinetic context

No half-life recorded in this source snapshot. No value has been inferred.

Source references

• GW501516 - DrugBank (availability check 2026-10-15: source not retrieved; HTTP 403)
• Metabolomic Study of GW501516 - PubMed Central (availability check 2026-10-15: possible access barrier; not independently inspected; HTTP 200)